🔗 Permalink

Inventor profile of:

Benjamin Anthony PRATT

City:

Encinitas, California

Country:

United States

Published Applications:

Last publication date:

2026-01-29

Top Assignees for applications by Benjamin Anthony PRATT

The entities that hold a legal rights for patent applications filed by inventor PRATT Benjamin Anthony:

Akarna Therapeutics, Ltd. 3 Cambridge, United Kingdom
AKARNA THERAPEUTICS, LTD. 2 London, United Kingdom
AKARNA THERAPEUTICS, LTD. 1 Lititz, PA United States
VASA THERAPEUTICS SPÓLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA 1 Wroclaw, Poland
Akarna Therapeutics, Ltd. 1 Allschwil, Switzerland
Recurium IP Holdings, LLC 1 San Diego, CA United States
Akarna Therapeutics, Ltd. 1 Hsinchu, Taiwan

Recent patent applications by PRATT Benjamin Anthony

Benjamin Anthony PRATT from Encinitas, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-29

US20260028363A1

Chemistry; metallurgy

CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL

#2 | 2025-07-03

US20250215010A1

Chemistry; metallurgy

DIAZABICYCLOOCTANE DERIVATIVES USEFUL AS MATRIX METALLOPROTEINASE INHIBITORS

#3 | 2025-06-26

US20250206753A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#4 | 2025-05-29

US20250171446A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#5 | 2025-01-23

US20250026761A1

Chemistry; metallurgy

DIAZABICYCLOOCTANE DERIVATIVES USEFUL AS MATRIX METALLOPROTEINASE INHIBITORS

#6 | 2024-01-25

US20240025914A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#7 | 2023-06-15

US20230183247A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#8 | 2023-01-05

US20230002426A1

Chemistry; metallurgy

CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL

#9 | 2023-01-05

US20230002394A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#10 | 2021-07-15

US20210214362A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#11 | 2021-05-20

US20210147426A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#12 | 2021-05-13

US20210139490A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#13 | 2020-12-31

US20200407364A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS

#14 | 2020-12-24

US20200397798A1

Human necessities

COMBINATION THERAPIES WITH FARNESOID X RECEPTOR (FXR) MODULATORS

#15 | 2020-10-15

US20200325140A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#16 | 2020-03-12

US20200079782A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#17 | 2019-10-10

US20190308977A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#18 | 2019-07-11

US20190211026A1

Chemistry; metallurgy

Fused bicyclic compounds for the treatment of disease

#19 | 2018-12-06

US20180346473A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS

#20 | 2018-05-03

US20180118752A1

Chemistry; metallurgy

Fused bicyclic compounds for the treatment of disease

#21 | 2017-12-14

US20170355704A1

Chemistry; metallurgy

Fused bicyclic compounds for the treatment of disease

#22 | 2017-12-14

US20170355699A1

Chemistry; metallurgy

Fused bicyclic compounds for the treatment of disease

InventorID:

2062486 ⎘